Showing results (791-800 of 815) with videos related to
Sort By:
Pageof 82
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.Acta Naturae|November 1, 2016
Biosynthesis of poly(3-hydroxybutyrateco-3-hydroxy-4-methylvalerate) by Strain Azotobacter chroococcum 7BA P Bonartsev, G A Bonartseva, V L Myshkina, et al.Terapevticheskii Arkhiv|August 25, 2005
[Cytogenetic response as a marker of efficacy of chronic myeloid leukemia therapy with a BCR-ABL thyrosine kinase inhibitor glivek]A G Turkina, S S Kruglov, G A Druzhkova, et al.Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.Terapevticheskii Arkhiv|August 28, 2009
[Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosine kinases]A G Turkina, E V Domracheva, A V Vorontsova, et al.Current Biology : CB|October 30, 2020
Genomes of Pleistocene Siberian Wolves Uncover Multiple Extinct Wolf LineagesJazmín Ramos-Madrigal, Mikkel-Holger S Sinding, Christian Carøe, et al.The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.JCI Insight|October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypesPatrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.Molecular Cancer|March 16, 2024
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effectsYufei Wang, Alicia Buck, Brandon Piel, et al.Pageof 82